Herberts Curt A. III

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$2.2M

Insider Activity of Herberts Curt A. III

The largest sale of all time was on 2018-03-01 and amounted to 15000 shares of Sangamo Therapeutics, Inc. for $345,861.

Biography of Herberts Curt A. III

No biography is available at this moment.

2018-04-13SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
8,163
0.0085%
$20.00$163,260-30.56%
2018-04-02SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
2,278
0.0024%
$18.30$41,684-21.44%
2018-03-01SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
15,000
0.017%
$23.06$345,861-37.06%
2018-02-01SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
15,000
0.0169%
$20.59$308,855-27.59%
2018-01-03SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
8,026
0.0096%
$18.05$144,869-9.77%
2018-01-02SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
6,974
0.0075%
$16.35$114,025-10.54%
2017-12-04SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
11,803
0.015%
$18.00$212,454-4.05%
2017-12-01SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
3,197
0.0038%
$16.70$53,390-3.02%
2017-11-30SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
13,433
0.0156%
$16.00$214,928-0.77%
2017-10-02SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
9,170
0.0103%
$15.41$141,304-0.15%
2017-09-01SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
10,316
0.013%
$15.00$154,740+12.98%
2017-08-14SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
5,000
0.0057%
$11.00$55,000+37.5%
2017-08-11SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
6,474
0.0075%
$10.00$64,740+55.61%
2017-07-14SaleSangamo Therapeutics, Inc.
SGMO
Sr.VP & Chief Business Officer
15,000
0.0177%
$10.00$150,000+57.92%
2017-06-01SaleSangamo Therapeutics, Inc.
SGMO
Senior VP & CBO
2,000
0.0027%
$6.80$13,600+123.93%
2017-05-12SaleSangamo Therapeutics, Inc.
SGMO
Senior VP & CBO
2,000
0.0029%
$8.50$17,000+79.88%
2017-05-11SaleSangamo Therapeutics, Inc.
SGMO
Senior VP & CBO
639
0.0008%
$6.50$4,154+110.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.